You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Phase Ib, TNBC, advanced, metastatic, immunotherapy, PDR001,

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

NSCLC (NSCLC), Triple Negative Breast Cancer (TNBC), Pancreatic Ductal Adenocarcinoma (PDAC) Trial in Worldwide (NZV930, PDR001,

Terminated
  • Non-small Cell Lung Cancer (NSCLC)
  • +6 more
  • NZV930
  • +2 more
  • Tampa, Florida
  • +9 more
Nov 2, 2022

TNBC Trial in Shanghai (PM8002, nab-paclitaxel)

Recruiting
  • TNBC
  • Shanghai, China
    Fudan University Shanghai Cancer Center
Jun 25, 2023

Metastatic and Advanced Solid Tumors Trial in United States (NIZ985, PDR001)

Completed
  • Metastatic and Advanced Solid Tumors
  • Bethesda, Maryland
  • +6 more
Mar 22, 2022

TNBC - Triple-Negative Breast Cancer Trial (A1:SG with SHR3680, A2:SG, B1:SG with SHR1210)

Not yet recruiting
  • TNBC - Triple-Negative Breast Cancer
  • A1:SG with SHR3680
  • +7 more
  • (no location specified)
Jun 23, 2023

NSCLC Trial in Shanghai (SI-B001, SI-B003)

Not yet recruiting
  • Non-small Cell Lung Cancer
  • Shanghai, Shanghai, China
    Shanghai Pulmonary Hospital
Jul 10, 2023

Advanced Malignancies Trial in Worldwide (MBG453, PDR001, Decitabine)

Terminated
  • Advanced Malignancies
  • Baltimore, Maryland
  • +13 more
Sep 20, 2022

Metastatic Breast Cancer, Solid Tumors Trial in Aurora (Alisertib, MLN0128)

Completed
Has Results
  • Metastatic Breast Cancer
  • Solid Tumors
  • Aurora, Colorado
    University of Colorado Cancer Center
May 17, 2022

Triple Negative Breast Cancer, Locally Advanced Breast Cancer, Unresectable Breast Carcinoma Trial in Aurora (Nab-paclitaxel,

Withdrawn
  • Triple Negative Breast Cancer
  • +4 more
  • Aurora, Colorado
    University of Colorado Hospital
Dec 2, 2022

Metastatic Colorectal Cancer Trial in Sutton (PDR001, bevacizumab, mFOLFOX6)

Terminated
  • Metastatic Colorectal Cancer
  • Sutton, Surrey, United Kingdom
    Novartis Investigative Site
Oct 7, 2021

Squamous Cell Carcinoma of Head and Neck Trial in Shanghai (SI-B001, SI-B003)

Not yet recruiting
  • Squamous Cell Carcinoma of Head and Neck
  • Shanghai, Shanghai, China
    Shanghai Oriental Hospital
Jan 13, 2023

Triple Negative Breast Cancer Trial in Shanghai (X4P-001)

Enrolling by invitation
  • Triple Negative Breast Cancer
  • Shanghai, Shang Hai, China
    Shang hai Tumor Hospital
Oct 20, 2021

Solid Tumors Trial in Worldwide (KAZ954, PDR001, NIR178)

Recruiting
  • Solid Tumors
  • Los Angeles, California
  • +12 more
Dec 23, 2022

NSCLC (NSCLC) Trial in Tampa (PBF-509_80 mg, PBF-509_160 mg, PBF-509_320 mg)

Completed
  • Non-small Cell Lung Cancer (NSCLC)
  • PBF-509_80 mg
  • +8 more
  • Tampa, Florida
    H.Lee Moffitt Cancer center
Jan 3, 2022

Solid Tumor Trial in Seoul (TASO-001((TGF-ß2 targeting anti-sense oligonucleotide), Aldesleukin)

Recruiting
  • Solid Tumor
  • TASO-001((TGF-β2 targeting anti-sense oligonucleotide)
  • Aldesleukin
  • Seoul, Korea, Republic of
    Seoul National University Hospital
Jan 31, 2023

Breast Cancer, Lung Cancer, Hepatocellular Cancer Trial in Worldwide (NIS793, PDR001)

Completed
  • Breast Cancer
  • +5 more
  • Nashville, Tennessee
  • +11 more
Jan 28, 2022

Gastrointestinal Stromal Tumors Trial in Seoul (PDR001, Imatinib)

Recruiting
  • Gastrointestinal Stromal Tumors
  • PDR001, Imatinib
  • Seoul, Korea, Republic of
    Asan Medical Center
Jun 22, 2021

NSCLC Trial in Worldwide (PDR001, Cisplatin, Gemcitabine)

Terminated
  • Non-small Cell Lung Cancer
  • Fayetteville, Arkansas
  • +22 more
Aug 11, 2022

Advanced Hepatocellular Carcinoma Trial in Worldwide (PDR001, INC280)

Completed
  • Advanced Hepatocellular Carcinoma
  • Toronto, Ontario, Canada
  • +16 more
Jul 29, 2021

Locally Advanced or Metastatic Solid Tumors, NSCLC, HNSCC Trial in Australia, United States (RO7502175, Atezolizumab)

Recruiting
  • Locally Advanced or Metastatic Solid Tumors
  • +10 more
  • Aurora, Colorado
  • +6 more
Jan 4, 2023

Nasopharyngeal Carcinoma Trial in Worldwide (Spartalizumab, Investigator choice of chemo)

Completed
Has Results
  • Nasopharyngeal Carcinoma
  • Marietta, Georgia
  • +17 more
Jan 17, 2022

Metastatic Pancreatic Adenocarcinoma, Stage IV Pancreatic Cancer AJCC v8 Trial in Atlanta (Siltuximab, Spartalizumab)

Recruiting
  • Metastatic Pancreatic Adenocarcinoma
  • Stage IV Pancreatic Cancer AJCC v8
  • Siltuximab
  • Spartalizumab
  • Atlanta, Georgia
  • +2 more
Feb 1, 2022

Clear Cell Renal Cell Carcinoma Metastatic, TNBC - Triple-Negative Breast Cancer, Head Neck Cancer Trial (CA9hu-1)

Not yet recruiting
  • Clear Cell Renal Cell Carcinoma Metastatic
  • +4 more
  • (no location specified)
Jan 13, 2023

Advanced Malignant Solid Tumor, Metastatic Malignant Solid Tumor, Recurrent Malignant Solid Tumor Trial (procedure, biological,

Not yet recruiting
  • Advanced Malignant Solid Neoplasm
  • +2 more
  • Biopsy
  • +5 more
  • (no location specified)
Apr 8, 2023

Head Neck Cancer Trial in Portland (INCAGN01876, INCMGA00012, DPV-001)

Recruiting
  • Cancer of the Head and Neck
  • Portland, Oregon
    Portland Providence Medical Center
Sep 1, 2021

Triple Negative Breast Cancer, Pancreatic Carcinoma, Melanoma Trial in Worldwide (MCS110, PDR001)

Completed
Has Results
  • Triple Negative Breast Cancer
  • +3 more
  • Boston, Massachusetts
  • +19 more
Jul 12, 2021